Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Patients benefit from advocating for themselves

When discussing the pros and cons of new drugs, new treatments, new studies or any new medical development with government regulators, people with different relationships to the health concern at hand often make up an advocacy group. 

Thumbnail

CMS star ratings debut with promise for continued updates

After several months of buildup, the CMS Hospital Compare website began to offer overall hospital star ratings July 27. 

FDA seeking comment on blood donation restrictions for gay men

The Food and Drug Administration (FDA) is formally asking for comments on whether it should change its policy of only allowing gay men to donate blood after they’ve been abstinent for one year.

Thumbnail

43 states given ‘F’ grades on health price transparency report card

According to an annual report card released by the Health Care Incentives Improvement Institute and Catalyst for Payment Reform, the vast majority of states aren’t meeting the groups’ minimum standards for providing consumers with easily accessible information on the prices of healthcare services.

Study: More than half of adults misuse their prescriptions

A majority of adults drug tested by Quest Diagnostics in 2015 were misusing their prescription drugs, according to a new study of patient results released by the clinical laboratory services company.

CDC expands Zika blood testing period for pregnant women to 14 days

Updated guidance from the Centers for Disease Control and Prevention (CDC) instructs physicians to test pregnant women for Zika up to 14 days after symptoms begin. It also adds new recommendations based on the first documented female-to-male transmission of the virus.

Florida providers going to trial in $360 million antitrust case against HealthFirst

Several healthcare providers and physicians in Florida are planning on going to trial with integrated system HealthFirst, seeking more than $360 million in damages for alleged antitrust violations.

Study: ACA cut hospital charity care, stabilized bad debt expenses

An analysis of CMS data by the Pittsburgh Post-Gazette said hospitals spent less on charity care and unrecoverable debt once the Affordable Care Act was implemented.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.